Biosysen Limited (HKG:1355)
Hong Kong · Delayed Price · Currency is HKD 0.1790
+0.0260 (16.99%)
Aug 4, 2026, 10:31 AM HKT
Biosysen Ratios and Metrics
Market cap in millions HKD. Fiscal year is January - December.
Millions HKD. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 181 | 149 | 98 | 102 | 107 | 137 | |
Market Cap Growth | 54.58% | 52.30% | -4.21% | -4.20% | -21.97% | -19.74% |
Enterprise Value | 273 | 220 | 219 | 239 | 264 | 322 |
Last Close Price | 0.15 | 0.10 | 0.12 | 0.15 | 0.15 | 0.19 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | - | - | - | - | - | 27.48 |
Forward PE | - | 22.40 | 22.40 | 22.40 | 22.40 | 22.40 |
PS Ratio | 3.53 | 2.91 | 2.41 | 1.51 | 1.69 | 1.94 |
PB Ratio | -1.76 | -1.45 | -0.93 | -1.24 | -5.11 | -69.35 |
P/TBV Ratio | - | - | - | - | 494.03 | 13.33 |
P/FCF Ratio | - | - | 4.08 | 2.96 | 16.65 | 9.73 |
P/OCF Ratio | - | - | 4.04 | 2.91 | 11.42 | 4.50 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 5.33 | 4.29 | 5.39 | 3.54 | 4.19 | 4.56 |
EV/EBITDA Ratio | - | - | 23.89 | - | 98.00 | 24.89 |
EV/EBIT Ratio | - | - | 134.37 | - | - | 67.43 |
EV/FCF Ratio | - | - | 9.13 | 6.93 | 41.19 | 22.90 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | -1.58 | -1.58 | -1.57 | -2.19 | -8.43 | -103.26 |
Debt / EBITDA Ratio | - | - | 6.43 | 9.13 | 7.33 | 5.84 |
Debt / FCF Ratio | - | - | 6.87 | 5.26 | 27.44 | 14.48 |
Net Debt / Equity Ratio | -1.55 | -1.55 | -1.43 | -2.17 | -8.12 | -94.61 |
Net Debt / EBITDA Ratio | -6.18 | -6.18 | 16.47 | -432.25 | 62.92 | 14.43 |
Net Debt / FCF Ratio | -3.22 | -3.22 | 6.29 | 5.20 | 26.44 | 13.27 |
Asset Turnover | 0.66 | 0.66 | 0.40 | 0.42 | 0.29 | 0.30 |
Inventory Turnover | 95.27 | 95.27 | 50.34 | 61.28 | 72.18 | 102.52 |
Quick Ratio | 0.10 | 0.10 | 0.22 | 0.07 | 0.28 | 0.29 |
Current Ratio | 0.23 | 0.23 | 0.24 | 0.11 | 0.32 | 0.31 |
Return on Equity (ROE) | - | - | - | - | - | -9795.12% |
Return on Assets (ROA) | -25.87% | -25.87% | 1.01% | -3.58% | -1.91% | 1.26% |
Return on Invested Capital (ROIC) | - | - | 6.84% | -12.24% | -5.13% | 2.72% |
Return on Capital Employed (ROCE) | 518.50% | 518.50% | 91.60% | -20.20% | -6.30% | 3.10% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | -24.00% | -29.19% | -21.57% | -37.35% | -7.30% | 3.64% |
FCF Yield | -27.36% | -33.26% | 24.52% | 33.76% | 6.01% | 10.28% |
Buyback Yield / Dilution | -71.06% | -71.06% | -25.81% | - | - | - |